Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting

A Phase II Study of Ara-C (Cytarabine) in Men With Androgen Independent Prostate Cancer (SLAP)

This study has been completed.
Information provided by (Responsible Party):
University Health Network, Toronto Identifier:
First received: May 28, 2007
Last updated: January 10, 2013
Last verified: January 2013
No Study Results Posted on for this Study
  Study Status: This study has been completed.
  Study Completion Date: July 2011
  Primary Completion Date: October 2010 (Final data collection date for primary outcome measure)